2017 AHA / ACC Update on 2014 Valvular Disease Q1

According to the
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Failure

“The risk of developing IE is higher in patients with underlying VHD.” (IE = infectve endocarditis,
VHD = valvular hear disease)

” … even in patients at high risk of IE, evidence for the efficacy of antibiotic prophylaxis is lacking … led to a revision in the 2007 AHA recommendations for prophylaxis limited to those patients at highest risk of adverse outcomes with IE (11).”

“These included patients with a history of prosthetic valve replacement, patients with prior IE, ______________________. “

a) patients with hypertrophic cardiomyopathy, patients with acquired valvular heart diseases and patients with unrepaired cyanotic heart diseases
b) and patients with acquired valvular heart diseases
c) select patients with congenital heart disease, and cardiac transplant recipients
d) and select patients with congenital heart disease

NOTE: THIS IS A SIMPLIFIED LISTING LACKING SOME DETAILS AND DOES NOT MENTION THAT BOTH 2007 and 2017 DOCUMENTS DISCUSS HISTORY OF PROSTHETIC VALVE REPAIR IN ADDITION TO VALVE REPLACEMENT

click here for answer

(C)

“These included patients with a history of prosthetic valve replacement, patients with prior IE, select patients with congenital heart disease, and cardiac transplant recipients.”

“Cardiac transplant with valve regurgitation due to a structurally abnormal valve.”

Leave Comment

Your email address will not be published. Required fields are marked *